Prototype Test For Predicting Clinical Outcome For Melanoma Patients

New cases in Pous 2064, HIV = 175, AIDS = 26, Death = 2. HIV rate is very high in Housewives than sex workers in Nepal ! ! ! HIV status in Nepal till 2005: Total Adult=70000, Adult Prevalence (15-49)=0.55%, Number of Women (15-49) LWHA=15,310 (22%), HIV Prevalence rate in IDUs=32.7%, HIV prevalence rate in sex worker=3.8%, HIV prevalence rate in client of SW=2.1%. The latest U.N. report shows that 65 million people have been infected with HIV since it was first identified 25 years ago. Twenty five million people have died of AIDS.

Welcome to the xenoMED, an online Medical Community where Academically sound, Professionally conscious and Socially responsible Medical Students, Doctors & Health Professionals interact with each other globally.

Medicine is the only profession that incessantly tries to destroy its own existence. Howsoever you may be associated with basic and/or clinical medicine - student or professor, physician or surgeon, undergraduate or postgraduate - this is your place to share your knowledge, and learn more. Just get the message across!

You are currently viewing our communiy as a guest which gives you limited access to view most discussions and access our other features. By joining our free community you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content and access many other special features. Registration is fast, simple and absolutely free so please, Join Our Medical Cummunity Today!

If you have any problems with the registration process or your account login, please contact us.

		xenoMED > News Room > Health News > ScienceDaily
Prototype Test For Predicting Clinical Outcome For Melanoma Patients

ScienceDaily Headlines: Health & Medicine

(#1 (permalink))

News is Offline

Senior Member

Posts: 749

Thanks: 0

Thanked 37 Times in 37 Posts

Join Date: Sep 2007

Prototype Test For Predicting Clinical Outcome For Melanoma Patients - 15-08-2008, 06:20 AM

Investigators have developed a test to predict whether a patient will progress rapidly from Stage III melanoma to metastatic Stage IV cancer and death. More than 70% of patients with Stage III melanoma ? melanoma that has spread to the lymph nodes ? will typically have a rapid time to progression (TTP) to Stage IV melanoma, and pass away within five years of their diagnosis.

More...

« Structural Biology Spin-out Tackles Major Diseases | Helping Tumor Cells Not To Stick To The Wound During Surgical Removal »

Thread Tools	Search this Thread
Show Printable Version Email this Page	Search this Thread: Advanced Search
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
Outcome For Bladder Cancer Patients Could Be Predicted By New Biomarker Test	Angel	Medical News Today	0	04-02-2007 07:01 PM
[RESEARCH] Effect of providing information about normal test results on patients' rea	Angel	BMJ	0	26-01-2007 02:52 AM
Docs Attacked after Kid’s Death in Hospital	नेपाली	Nepal Health News	6	27-12-2006 07:03 PM
Test to Predict Heart-Attack Risk Underused	GUNNER	Medical Breakthrough	0	15-03-2006 10:16 PM

Hosted and Maintained by: